医学临床研究
  2025年4月5日 星期六           首 页    |    期刊简介    |    编委会    |    投稿指南    |    期刊订阅    |    广告合作    |    留言板    |    联系我们    |    English
医学临床研究  2022, Vol. 39 Issue (9): 1318-1321    DOI: 10.3969/j.issn.1671-7171.2022.09.011
  论著 本期目录 | 过刊浏览 | 高级检索 |
前列腺素E1预防急性心肌梗死患者PCI术后肾功能损伤的价值
陈伟1, 周静2**
1.商洛市中心医院药学部,陕西 商洛 726000;
2.延安大学附属医院心血管病中心,陕西 延安 716000
Value of Prostaglandin E1 in Preventing Renal Function Injury after PCI in Patients with Acute Myocardial Infarction
CHEN Wei, ZHOU Jing
Shangluo Central Hospital,Shangluo Shaanxi 726000
全文: PDF (1140 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 【目的】探讨前列腺素E1(PGE1)预防急性心肌梗死(AMI)患者经皮冠状动脉介入(PCI)术后肾功能损伤的价值。【方法】选取2019年5月至2020年5月商洛市中心医院收治的84例行PCI治疗的AMI患者,根据随机数字表法将其分为观察组与对照组,每组42例。两组均行PCI术,对照组于PCI术前及术后常规静脉补液水化,观察组在对照组基础上给予静脉滴注前列地尔。比较两组造影剂肾病(CIN)及术后不良事件发生率,比较两组手术前后肾功能指标[血肌酐(Cr)、胱抑素C(cys C)、血尿素氮(BUN)、肌酐清除率(Ccr)]及血管内皮功能指标[内皮素(ET-1)、一氧化氮(NO)、脂联素(APN)]。【结果】84例患者发生CIN共计18例,其中观察组发生CIN共计2例(4.76%),对照组发生CIN共计16例(38.10%),观察组CIN发生率显著低于对照组,差异有统计学意义(χ2=13.859,P=0.000)。术后7 d,两组患者Cr、cys C、BUN高于术前,Ccr低于术前,且观察组与对照组比较,差异均有统计学意义(P<0.05);两组患者ET-1低于术前,NO、APN高于术前,且观察组与对照组比较,差异均有统计学意义(均P<0.05)。观察组术后不良事件总发生率为9.52%(4/42),低于对照组的14.29%(6/42),但差异无统计学意义(χ2=0.45,P=0.50)。【结论】PGE1可有效预防AMI患者PCI术后肾功能与内皮功能的损伤,值得临床借鉴应用。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
陈伟
周静
关键词 心肌梗死/治疗急性病前列腺素E类经皮冠状动脉介入治疗肾功能不全    
Abstract:【Objective】 To investigate the value of prostaglandin E1 (PGE1) in preventing renal function injury after percutaneous coronary intervention (PCI) in patients with acute myocardial infarction (AMI). 【Methods】 A total of 84 AMI patients treated by PCI in Shangluo Central Hospital from May 2019 to May 2020 were selected and divided into the observation group and the control group according to the random number table, with 42 patients in each group. Both groups underwent PCI. The control group received routine intravenous rehydration before and after PCI. The observation group received intravenous drip of alprostadil on the basis of the control group. The contrast agent nephropathy (CIN) and the incidence of adverse events after operation were compared between the two groups. The renal function indexes [serum creatinine (Cr), cystatin C (cys C), blood urea nitrogen (BUN), creatinine clearance rate (Ccr)] and vascular endothelial function indexes [endothelin (ET-1), nitric oxide (NO), adiponectin (APN)] before and after operation were compared between the two groups. 【Results】There were 18 cases of CIN in 84 patients, including 2 cases (4.76%) in the observation group and 16 cases (38.10%) in the control group. The incidence of CIN in the observation group was significantly lower than that in the control group, with a statistically significant difference(χ2=13.859,P=0.000).On the 7th day after operation, the Cr, cys C, BUN of the two groups were higher than those before operation, and the Ccr was lower than that before operation. The difference between the observation group and the control group was statistically significant (P<0.05); ET-1 in the two groups was lower than that before operation, and NO and APN were higher than that before operation. The difference between the observation group and the control group was statistically significant (both P<0.05). The total incidence of adverse events in the observation group was 9.52% (4/42), lower than 14.29% (6/42) in the control group, but the difference was not statistically significant(χ2=0.45,P=0.50).【Conclusion】 PGE1 can effectively prevent the damage of renal function and endothelial function in AMI patients after PCI, which is worthy of clinical reference.
Key wordsMyocardial Infarction/TH    Acute Disease    Prostaglandins E    Percutaneous Coronary Intervention    Renal Insufficiency
收稿日期: 2022-03-16     
中图分类号:  R542.22  
基金资助:2020年度陕西省科技厅-重点研发计划一般项目(2021SF-254)
通讯作者: **E-mail:25891082@qq.com   
引用本文:   
陈伟, 周静. 前列腺素E1预防急性心肌梗死患者PCI术后肾功能损伤的价值[J]. 医学临床研究, 2022, 39(9): 1318-1321.
CHEN Wei, ZHOU Jing. Value of Prostaglandin E1 in Preventing Renal Function Injury after PCI in Patients with Acute Myocardial Infarction. JOURNAL OF CLINICAL RESEARCH, 2022, 39(9): 1318-1321.
链接本文:  
http://journal07.magtech.org.cn/yxlcyj/CN/10.3969/j.issn.1671-7171.2022.09.011     或     http://journal07.magtech.org.cn/yxlcyj/CN/Y2022/V39/I9/1318
版权所有 © 2013 医学临床研究杂志社  湘ICP备13012052号-1
办公地址:湖南省长沙市芙蓉区新军路43号煤炭大院主办公楼6楼621、623、632、636室 邮编:410011 电话(传真):0731-84824007 E-mail:jcr_cs.hn@vip.163.com
技术支持:北京玛格泰克科技发展有限公司 技术支持:support@magtech.com.cn